Search
Biodesix Inc
BDSXAdd to Watchlist
27.400USD
+0.435+1.61%
Close 09-14 16:00（ET）
285.74MMarket Cap
LossP/E TTM
Biodesix Inc (BDSX) Stock Price Target & Forecast
Analyst Rating
Based on 7 analysts giving stock ratings to Biodesix Inc in the past month.
Buy
1 Strong Buy
6 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
32.800USD+21.64%
BDSX Analyst Recommendation Trends
In the current month, BDSX has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BDSX average Analyst price target in the last month is 32.800.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
0
0
0
6
6
4
4
4
4
4
4
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
5
5
5
5
5
5
BDSX Analyst Rating for Peer Comparison
Updated: Sep 14, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
CVS Health Corp
CVS
7
18
4
0
0
29
HCA Healthcare Inc
HCA
5
9
11
1
0
26
Teladoc Health Inc
TDOC
2
4
19
0
0
25
Natera Inc
NTRA
10
11
3
0
0
24
Tenet Healthcare Corp
THC
5
15
3
0
0
23
Universal Health Services Inc
UHS
2
4
15
1
0
22
Privia Health Group Inc
PRVA
6
12
2
0
0
20
Labcorp Holdings Inc
LH
7
9
4
0
0
20
Quest Diagnostics Inc
DGX
5
5
9
0
0
19
Brightspring Health Services Inc
BTSG
7
12
0
0
0
19
Financial Forecasting
Based on analysts' estimates, BDSX EPS is projected to reach -0.750 in FY2026Q3, following reported EPS of -0.706 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.85
-1.10
-0.90
-0.75
-0.43
Actual
-0.49
-0.81
-0.71
--
--
Surprise
+42.32%
+26.36%
+21.71%
--
--
FAQs
What is Biodesix Inc's expected revenue for the next quarter?
Biodesix Inc's expected revenue is 27.56M.
What is Biodesix Inc's price target?
Analysts forecast that Biodesix Inc's price target is USD 32.80, with the highest forecast at USD 40.00 and the lowest forecast at USD 27.00.
How have Biodesix IncBDSX's recent earnings per share performed?
The market expectation was USD -0.71, while Biodesix IncBDSX's earnings per share (EPS) for the previous quarter was USD -0.81. EPS for the next quarter is expected at USD -0.75.
What is the analyst rating for Biodesix Inc?
Based on the ratings of Biodesix Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.